MedTech Europe urges EU to regulate Third-Party Litigation Funding

Article summary

MedTech Europe, along with other European industry bodies, has called for EU regulatory oversight of Third-Party Litigation Funding (TPLF). The organisation has expressed concern over the unregulated growth of TPLF, which it claims encourages profit-driven litigation financing and potentially abusive practices. MedTech Europe advocates for a regulatory framework that promotes transparency, ensures fair compensation, and protects all parties from exploitation. The aim is to safeguard the integrity of civil justice and maintain a competitive business environment across the EU.